Fagron NV

€24.20As of Sun 8 Nov 2026, 12:00 UTC
EBR:FAGRHealthcare
Country Belgium
PE (Fwd) •••
TSR 10Y CAGR 11.17%
Div yield 1.65%
ROE 16.70%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.32
PE TTM 19.36
TSR TTM 18.84%
Mkt cap €1.775B
ROIC 10.57%
SE Grade™
Value
Quality
Moat
Consensus
Reference
€23
(3.61%)
(47.39%)
Hold 2|5|8|7|6
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.30
0.31
0.32
0.36
16.36%
12.19%
10.27%
17.73%
Revenue€M
122.0
119.3
123.4
123.4
3.71%
0.17%
0.95%
2.19%
Peers (US$1.993B)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
2.486
(0.197)
(0.204)
EBIT/Intx
0.230
0.436
0.391
Own earn%
(132.04)
295.19
274.17
Sh yield%
27.77
27.06
25.54
Owners
Insiders/Inst%
10.13
29.91
Short interest%
0.87
SBC / revenue%
2.29
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
16–26
$1 testx
0.0
Incr. ROIC%
8